Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234156 · ClinicalTrials.gov registry record · NA
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00234156 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 30 participants.
The verdict
NCT00234156, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will evaluate how a common dietary sugar (fructose) raises blood fats (triglycerides). We will determine whether the production of fat from fructose is higher in dialysis patients compared to healthy volunteers. Dialysis patients have high levels of hormone-like substances called cytokines that may increase blood fats. The results will help set better guidelines for diets for the general population and patients with kidney disease who are at high risk for heart attack and stroke. There will be one or two outpatient screening visit(s) and a one-week (6 nights) stay at the Rockefeller University Hospital.
Interventions
- PROCEDURE oral fructose and high fat diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00234156
The ClinicalTrials.gov registry entry for NCT00234156 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral fructose and high fat diet is the first listed.
NCT00234156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00234156 about?
NCT00234156 is a clinical study titled "The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers". This study will evaluate how a common dietary sugar (fructose) raises blood fats (triglycerides). We will determine whether the production of fat from fructose is higher in dialysis patients compared to healthy volunteers. Dialysis patients have high levels of hormone-like substances called cytokine...
What is the current status of trial NCT00234156?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2004-09. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00234156?
The interventions under investigation include: oral fructose and high fat diet (PROCEDURE).
Who is sponsoring clinical trial NCT00234156?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.